Athens, Greece

Avgi Mamalaki

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal2 out of 2 
 
Zestagen S.a.
 patents
silverMedal1 out of 2 
 
Hellenic Pasteur Institute
 patents
bronzeMedal1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 2013-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Avgi Mamalaki: Innovator in Neoplasia Treatment

Introduction

Avgi Mamalaki is a notable inventor based in Athens, Greece. He has made significant contributions to the field of medical research, particularly in the treatment of neoplasia. With a total of 3 patents to his name, Mamalaki's work focuses on innovative therapeutic methods.

Latest Patents

Mamalaki's latest patents include groundbreaking inventions such as "Methods for treating neoplasia" and "Compositions and methods for treating neoplasia." These inventions provide therapeutic methods that utilize chimeric human/mouse antibodies for the treatment of neoplasia, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Mamalaki has worked with various companies, including Zestagen S.A. His experience in the industry has allowed him to develop and refine his innovative ideas, contributing to the advancement of treatment options for neoplasia.

Collaborations

Mamalaki has collaborated with esteemed colleagues, including Katerina Sidera and Evangelia Patsavoudi. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.

Conclusion

Avgi Mamalaki's contributions to the field of neoplasia treatment through his patents and collaborations highlight his role as an influential inventor. His innovative approaches continue to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…